Page last updated: 2024-10-18

dalteparin and Hemolysis

dalteparin has been researched along with Hemolysis in 4 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.

Research Excerpts

ExcerptRelevanceReference
"Pain is the most prominent symptom of vasoocclusion, and hypercoagulability is a well-established pathogenic phenomenon in people with sickle cell disease."2.50Low-molecular-weight heparins for managing vasoocclusive crises in people with sickle cell disease: a summary of a cochrane systematic review. ( Fedorowicz, Z; van Zuuren, EJ, 2014)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Al-Sallami, HS1
Medlicott, NJ1
Balestrino, D1
Quintana, M1
Charbonnel, N1
Forestier, C1
Lartigue, C1
Souweine, B1
Mannari, D1
Liu, C1
Hughes, D1
Mehta, A1
van Zuuren, EJ1
Fedorowicz, Z1

Reviews

1 review available for dalteparin and Hemolysis

ArticleYear
Low-molecular-weight heparins for managing vasoocclusive crises in people with sickle cell disease: a summary of a cochrane systematic review.
    Hemoglobin, 2014, Volume: 38, Issue:3

    Topics: Anemia, Sickle Cell; Female; Fibrinolytic Agents; Hemolysis; Heparin, Low-Molecular-Weight; Humans;

2014

Other Studies

3 other studies available for dalteparin and Hemolysis

ArticleYear
Investigation of an anti-activated factor X (anti-Xa) assay for the quantification of enoxaparin in human plasma.
    The Journal of pharmacy and pharmacology, 2015, Volume: 67, Issue:2

    Topics: Anticoagulants; Antithrombin III; Enoxaparin; Factor Xa; Freezing; Hemolysis; Humans; Male; Thrombos

2015
Compatibility of Injectable Anticoagulant Agents in Ethanol; In Vitro Antibiofilm Activity and Impact on Polyurethane Catheters of Enoxaparin 400 U/mL in 40% v/v Ethanol.
    PloS one, 2016, Volume: 11, Issue:7

    Topics: Albumins; Anticoagulants; Biofilms; Catheters; Chemical Fractionation; Chemical Precipitation; Chrom

2016
The role of heparin in alleviating complement-mediated acute intravascular haemolysis.
    Acta haematologica, 2008, Volume: 119, Issue:3

    Topics: 3' Untranslated Regions; Acute Disease; Adult; Anemia, Hemolytic, Autoimmune; Azathioprine; Combined

2008